ANALISIS EFEKTIVITAS BIAYA PERAWATAN TERAPI GASTRITIS ANTARA OMEPRAZOLE DAN RANITIDIN DI UNIT RAWAT INAP RSUD Ir. SOEKARNO SUKOHARJO PERIODE TAHUN 2017

Hae, Mage Dara (2018) ANALISIS EFEKTIVITAS BIAYA PERAWATAN TERAPI GASTRITIS ANTARA OMEPRAZOLE DAN RANITIDIN DI UNIT RAWAT INAP RSUD Ir. SOEKARNO SUKOHARJO PERIODE TAHUN 2017. Skripsi thesis, Universitas Setia Budi.

	Text 1. Intisari dan Abstrak.pdf Download (152kB)
	Text 2. form pernyataan publikasi_Mage Dara Hae.pdf Download (137kB)
	Text 3. Bab 1.pdf Download (620kB)
	Text 4. Bab 2.pdf Restricted to Repository staff only Download (442kB) | Request a copy
	Text 5. Bab 3.pdf Restricted to Repository staff only Download (392kB) | Request a copy
	Text 6. Bab 4.pdf Restricted to Repository staff only Download (279kB) | Request a copy
	Text 7. Bab 5 dan Lampiran.pdf Download (1MB)

Abstract

Gastritis is inflammation of the gastric mucosa caused by various factors such as infection with helicobacter pylori, stress, NSAIDs, food and alcohol which are acute and chronic. The aim of the study was to analyze the cost effectiveness of hospitalized gastritis patients using omeprazole or ranitidine. The type of research is observational with cross-sectional method according to hospital perspective. This study used secondary data on gastritis patients from January to December 2017 regarding gastritis treatment for 60 class III BPJS patients. Data taken includes demographic data, length of stay, total costs and patients who meet the inclusion criteria. As many as 30 patients took the drug omeprazole gastritis and 27 gastritis patients who used ranitidine. The patient's age ranges from 17-80 years. The statistical analysis performed was an independent t�test. The results showed that the duration of stay was 1-3 days omeprazole (69.7%) and ranitidine (59.3%). The average total cost of therapy for omeprazole is Rp. 548,619.79 and ranitidine Rp. 504,954.89 with a probability of 0.881> 0.005 where the results are not significantly different from omeprazole therapy more effective than ranitidine with a percentage value of 75.76% and 66.67% respectively. Value ACER therapy for omeprazole Rp. 7,241.55 / 1% recovery was lower than ranitidine Rp. 7,573.95 / 1%. ICER value of omeprazole and ranitidine therapy 5,133.65 / 1% So omeprazole is more cost effective than ranitidine. Keyword : Cost effectiviness Analysis, gastritis, omeprazole, ranitidine.

Item Type:	Thesis (Skripsi)
Uncontrolled Keywords:	Cost effectiviness Analysis, gastritis, omeprazole, ranitidine.
Subjects:	R Medicine > RS Pharmacy and materia medica
Divisions:	Fakultas Farmasi > Prodi S1 Farmasi
Depositing User:	Tifany Nur Arfiana
Date Deposited:	29 Mar 2022 07:55
Last Modified:	29 Mar 2022 07:55
URI:	http://repo.setiabudi.ac.id/id/eprint/4681

Actions (login required)

View Item